There is a newer version of the record available.

Published February 20, 2023 | Version v2

Assessment of covalently binding warhead compounds in the validation of the cytomegalovirus nuclear egress complex as an antiviral target

  • 1. Friedrich-Alexander University of Erlangen-Nürnberg
  • 2. Hannover Medical School
  • 3. Lead Discovery Center GmbH, Dortmund

Description

Supplementary to the publication:

"Assessment of covalently binding warhead compounds in the validation of the cytomegalovirus nuclear egress complex as an antiviral target" (2023), published in Cells

Raw images of the Figures 2, 8 and 11

Notes

This research of herpesviral nuclear egress and the development of antiviral small molecues was funded by Deutsche Forschungsgemeinschaft/DFG (German Research Foundation–401821119, Research Training Group GRK2504 for M.M. and J.T.), DFG (grant MA1289/11-1/11-3), Bayerische Forschungsstiftung (grant DeeP-CMV/AP-5/M.M.), and Volkswagenstiftung (grant Az9B783).

Files

Tillmanns et al_2023.zip

Files (29.2 MB)

Name Size Download all
md5:9b87ee334d550f978496829893239800
29.2 MB Preview Download